Compare Tenet Healthcare Corporation (THC) vs Global X Uranium ETF (URA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Global X Uranium ETF — how do they compare? Tenet Healthcare Corporation trades at $263.55 (market cap $20.89B), while Global X Uranium ETF trades at $45.19. The key difference: Tenet Healthcare Corporation is trading nearer its 52-week high, Global X Uranium ETF nearer its low. Which is the better fit depends on your goals.
| THC | URA | |
|---|---|---|
Market Cap | $20.89B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $262.63 | $61.81 |
52-Week Low | $161.37 | $36.45 |
Enterprise Value | $31.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $260.67, up 0.28% today, with strong technical momentum including a golden cross pattern and bullish moving average alignment. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $6.12 versus $4.26 forecast, maintaining a three-quarter earnings beat streak. Valuation metrics remain attractive with P/E of 10.03 and EV/EBITDA of 5.73, while profitability metrics show exceptional ROE of 53.31% and net margin of 9.9%.
The investment outlook remains positive with 81% analyst buy ratings and $281.44 consensus price target representing 8% upside. Key risks include policy headwinds in ACA exchanges and hospital segment challenges, though strong ambulatory growth provides offset. The stock presents a compelling value-growth combination with momentum characteristics, supported by institutional accumulation and positive earnings revisions.
URA, the Global X Uranium ETF, trades at $45.63, up 2.82% with a bullish technical signal from moving averages. The ETF benefits from strong policy support including $17.5 billion in federal nuclear funding and growing AI power demand. Recent index additions like Terra Innovatum and Eagle Nuclear Energy expand exposure to nuclear supply chain companies. RSI_6 at 92.76 indicates potential short-term overbought conditions while ADX signals strong trend momentum.
The uranium sector outlook remains positive with nuclear energy positioned as a solution to AI power demands and global energy security needs. Key risks include ETF concentration in uranium miners and sensitivity to commodity price volatility. Support at $45 and resistance at $46 will be critical for near-term price direction as the sector capitalizes on nuclear renaissance tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →
